Latest News & Features
Americas
Japanese pharmaceutical company Otsuka Pharmaceutical has filed a complaint against Indian company Ajanta Pharma for allegedly infringing a patent for its bipolar and schizophrenia medication, Abilify (aripiprazole). 2 September 2016
Americas
Dublin-based pharmaceutical company Allerganhas revealed that its subsidiaries, Forest Laboratories and Adamas Pharmaceuticals, have entered into a settlement agreement with Amneal Pharmaceuticals. 1 September 2016
Americas
The University of Minnesota has sued Gilead Sciences for allegedly infringing the university’s patent by selling drugs containing sofosbuvir. 1 September 2016
Big Pharma
While we await the outcome of the appeal in Warner-Lambert v Actavis, which concerns second medical use patents, there are several steps drugs companies should take given the need to balance the interests of patent owners and generic makers. Clare Greatbanks of Osborne Clarke reports. 1 September 2016
Americas
UK-based company AstraZeneca will have to pay $5.5 million to resolve a bribery case after allegedly falsely rewarding healthcare officials in China and Russia. 31 August 2016
Americas
Diagnostics company Alere has filed a complaint against Abbott in the Delaware Chancery Court in an attempt to compel Abbott to fulfil its obligations surrounding the companies’ merger agreement. 31 August 2016
Big Pharma
Pharmaceutical company Boehringer Ingelheim has entered into a research collaboration with Saniona, a Danish based pharma company. 30 August 2016
Americas
Gilead Sciences and Emory University’s patent infringement claims against Indian pharma company Hetero Drugs have been dismissed. 30 August 2016
Americas
Although the biosimilar market in the US is still early in development, US payers believe that the expected cost savings offered by biosimilar products have yet to materialise. 26 August 2016
Asia
The European Medicines Agency has accepted pharmaceutical company Mylan’s request to review its application for a biosimilar of Herceptin. 26 August 2016